{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:57:42Z","timestamp":1790697462508,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81274068"],"award-info":[{"award-number":["81274068"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Administration of Traditional Chinese Medicine of Jiangsu Province","award":["LZ11066"],"award-info":[{"award-number":["LZ11066"]}]},{"name":"Key Laboratory of New Drug Delivery System of Chinese Materia Medica in Jiangsu Province Academy of Traditional Chinese Medicine","award":["2011NDDCM02003"],"award-info":[{"award-number":["2011NDDCM02003"]}]},{"name":"Foundation for High-level Talent on six areas of the Jiangsu province"},{"name":"Suzhou City Science and Technology Development Plan","award":["ZXY2012009"],"award-info":[{"award-number":["ZXY2012009"]}]},{"name":"Key Laboratory of Traditional Chinese Medicine Oral Preparation of Chinese Traditional Medicine Release System","award":["2011NDDCM01001"],"award-info":[{"award-number":["2011NDDCM01001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Fitoterapia"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.fitote.2012.09.013","type":"journal-article","created":{"date-parts":[[2012,9,21]],"date-time":"2012-09-21T15:16:52Z","timestamp":1348240612000},"page":"64-71","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["A nanostructured liquid crystalline formulation of 20(S)-protopanaxadiol with improved oral absorption"],"prefix":"10.1016","volume":"84","author":[{"given":"Xin","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-hai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-bin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-bin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fitote.2012.09.013_bb0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF02980048","article-title":"Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants","volume":"27","author":"Bae","year":"2004","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.fitote.2012.09.013_bb0010","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1124\/dmd.31.8.1065","article-title":"Degradation of ginsenosides in humans after oral administration","volume":"31","author":"Tawab","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.fitote.2012.09.013_bb0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jchromb.2004.12.028","article-title":"High performance liquid chromatographic-mass spectrometric determination of ginsenoside Rg3 and its metabolites in rat plasma using solid-phase extraction for pharmacokinetic studies","volume":"818","author":"Xie","year":"2005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.fitote.2012.09.013_bb0020","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.3390\/molecules161210619","article-title":"The in vitro structure-related anti-cancer activity of ginsenosides and their derivatives","volume":"16","author":"Dong","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.fitote.2012.09.013_bb0025","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1742-7843.2006.pto_415.x","article-title":"Ginsenoside 20(S)-protopanaxadiol inhibits the proliferation and invasion of human fibrosarcoma HT1080 cells","volume":"98","author":"Li","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.fitote.2012.09.013_bb0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1021\/np060313t","article-title":"20S-protopanaxadiol-induced programmed cell death in glioma cells through caspase-dependent and -independent pathways","volume":"70","author":"Liu","year":"2007","journal-title":"J Nat Prod"},{"key":"10.1016\/j.fitote.2012.09.013_bb0035","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejphar.2011.06.008","article-title":"20(S)-protopanaxadiol, a metabolite of ginsenosides, induced cell apoptosis through endoplasmic reticulum stress in human hepatocarcinoma HepG2 cells","volume":"668","author":"Zhu","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.fitote.2012.09.013_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0003-9861(02)00398-3","article-title":"Structure\u2013function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line","volume":"406","author":"Popovich","year":"2002","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.fitote.2012.09.013_bb0045","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1021\/np070613q","article-title":"Antitumor agents. 261. 20(S)-protopanaxadiol and 20(S)-protopanaxatriol as antiangiogenic agents and total assignment of 1H NMR spectra","volume":"71","author":"Usami","year":"2008","journal-title":"J Nat Prod"},{"key":"10.1016\/j.fitote.2012.09.013_bb0050","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00280-006-0300-z","article-title":"In vitro anti-cancer activity and structure\u2013activity relationships of natural products isolated from fruits of Panax ginseng","volume":"59","author":"Wang","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.fitote.2012.09.013_bb0055","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1002\/cncr.22659","article-title":"Antiestrogenic effect of 20S-protopanax-adiol and its synergy with tamoxifen on breast cancer cells","volume":"109","author":"Yu","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.fitote.2012.09.013_bb0060","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2116\/analsci.26.749","article-title":"Development of a UPLC-ESI-MS\/MS assay for 20(S)-Protopanaxadiol and pharmacokinetic application of its two formulations in rats","volume":"26","author":"Han","year":"2010","journal-title":"Anal Sci"},{"key":"10.1016\/j.fitote.2012.09.013_bb0065","first-page":"569","article-title":"Controlled crystallization of the lipophilic drug fenofibrate during freeze-drying: elucidation of the mechanism by in-line Raman spectroscopy","volume":"12","author":"De Waard","year":"2010","journal-title":"APPS J"},{"key":"10.1016\/j.fitote.2012.09.013_bb0070","first-page":"13","article-title":"Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate\/poloxamer 407 cubic nanoparticles","volume":"5","author":"Lai","year":"2010","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.fitote.2012.09.013_bb0075","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1248\/bpb.30.350","article-title":"Cubosomes: an overview","volume":"30","author":"Gopal","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.fitote.2012.09.013_bb0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drudis.2010.09.006","article-title":"Lyotropic liquid crystal systems in drug delivery","volume":"15","author":"Guo","year":"2010","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.fitote.2012.09.013_bb0085","first-page":"3703","article-title":"Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption","volume":"7","author":"Zeng","year":"2012","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.fitote.2012.09.013_bb0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0378-5173(02)00298-3","article-title":"Preparation and structural investigations of colloidal dispersions prepared from cubic monoglyceride-water phases","volume":"244","author":"Siekmann","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.fitote.2012.09.013_bb0095","first-page":"E30","article-title":"Lipid-based supramolecular systems for topical application: a preformulatory study","volume":"18","author":"Esposito","year":"2003","journal-title":"AAPS PharmSci"},{"key":"10.1016\/j.fitote.2012.09.013_bb0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0378-5173(94)00280-I","article-title":"Characterisation of a newly isolated Caco-2 clone (TC-7), as a model of transport processes and biotransformation of drugs","volume":"166","author":"Caro","year":"1995","journal-title":"Int J Pharm"},{"key":"10.1016\/j.fitote.2012.09.013_bb0105","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.fitote.2012.06.013","article-title":"In vitro intestinal transport of oligomeric procyanidins (DP 2 to 4) across monolayers of Caco-2 cells","volume":"7","author":"Zumdick","year":"2012","journal-title":"Fitoterapia"},{"key":"10.1016\/j.fitote.2012.09.013_bb0110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.fitote.2009.02.005","article-title":"The effect of berberine in vitro on tight junctions in human Caco-2 intestinal epithelial cells","volume":"4","author":"Gu","year":"2009","journal-title":"Fitoterapia"},{"key":"10.1016\/j.fitote.2012.09.013_bb0115","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.fitote.2006.09.003","article-title":"\u03b1-Glucosidase inhibitory effect of mulberry (Morus alba) leaves on Caco-2","volume":"8","author":"Hansawasdi","year":"2006","journal-title":"Fitoterapia"},{"key":"10.1016\/j.fitote.2012.09.013_bb0120","first-page":"293","article-title":"Preparation of icariside II-phospholipid complex and its absorption across Caco-2 cell monolayers","volume":"67","author":"Jin","year":"2012","journal-title":"Pharmazie"},{"key":"10.1016\/j.fitote.2012.09.013_bb0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0300-483X(02)00555-3","article-title":"Intestinal permeability of chlorpyrifos using the single-pass intestinal perfusion method in the rat","volume":"184","author":"Cook","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.fitote.2012.09.013_bb0130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2010.06.015","article-title":"Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: improving preocular retention and ocular bioavailability","volume":"396","author":"Li","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.fitote.2012.09.013_bb0135","first-page":"2253","article-title":"Functionalized carbon nanomaterials: exploring the interactions with Caco-2 cells for potential oral drug delivery","volume":"6","author":"Coyuco","year":"2011","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.fitote.2012.09.013_bb0140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejpb.2010.12.006","article-title":"Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model","volume":"77","author":"Wahlang","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.fitote.2012.09.013_bb0145","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jconrel.2011.03.033","article-title":"Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration","volume":"153","author":"Nguyen","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.fitote.2012.09.013_bb0150","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijpharm.2007.03.020","article-title":"A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats","volume":"340","author":"Boyd","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.fitote.2012.09.013_bb0155","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1021\/la970566+","article-title":"Submicron particles of reversed lipid phases in water stabilized by a nonionic amphiphilic polymer","volume":"13","author":"Gustafsson","year":"1997","journal-title":"Langmuir"},{"key":"10.1016\/j.fitote.2012.09.013_bb0160","first-page":"435","article-title":"Evaluation of nanosuspensions for absorption enhancement of poorly soluble drugs: in vitro transport studies across intestinal epithelial monolayers","volume":"10","author":"Lenhardt","year":"2008","journal-title":"APPS J"},{"key":"10.1016\/j.fitote.2012.09.013_bb0165","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1139\/y93-078","article-title":"Lipid absorption: passing through the unstirred layers, brush-border membrane, and beyond","volume":"71","author":"Thomson","year":"1993","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.fitote.2012.09.013_bb0170","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1211\/jpp.60.10.0007","article-title":"An evaluation of the relative roles of the unstirred water layer and receptor sink in limiting the in-vitro intestinal permeability of drug compounds of varying lipophilicity","volume":"60","author":"Katneni","year":"2008","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.fitote.2012.09.013_bb0175","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1002\/jps.21762","article-title":"Analysis of unstirred water layer in in vitro permeability experiments","volume":"98","author":"Korjamo","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.fitote.2012.09.013_bb0180","article-title":"Crystalline nanosuspensions as potential toxicology and clinical oral formulations for BCS II\/IV compounds","author":"Kesisoglou","year":"2012","journal-title":"APPS J"}],"container-title":["Fitoterapia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X12002602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X12002602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T16:23:19Z","timestamp":1542730999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0367326X12002602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":36,"alternative-id":["S0367326X12002602"],"URL":"https:\/\/doi.org\/10.1016\/j.fitote.2012.09.013","relation":{},"ISSN":["0367-326X"],"issn-type":[{"value":"0367-326X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}